Latest News

A selection of recent news and views from Catapult Ventures follows...

Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics

Shanghai China and Oxford UK, December 11, 2018 –WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing and Oxford Bio...

Med-Tech companies triumph at the Bionow Awards

The outstanding companies and leaders of the North’s life sciences sector – which is worth more than £13bn to the economy- were honoured last night at the 17th annual Bionow Awards. More than 300 people attended the awards d...

Blueberry Therapeutics Announce Positive Results from a Phase I-II Clinical Trial

Alderley Park, UK, 21stNovember 2018– Blueberry Therapeutics Limited (“Blueberry Therapeutics”), a modern drug discovery and development company committed to the development of innovative new therapies for the treatment of common...

Biofilm seals £2.5m funding injection

Biofilm has secured a £2.5 million funding package to increase production capacity and expand its product range. Biofilm, which was originally launched as a subsidiary of food products firm Devro, specialises in fast dissolving and absorbab...

R2C Online wins at 2018 Commercial Motor Awards

Delighted to announce that Catapult portfolio company R2C Online have won the award for Workshop Innovation of the Year at the 2018 Commercial Motor Awards.  Read more about the event and the winners...

From our portfolio



Ergomed is developing first-in-class clotting agents for the treatment of bleeding or 'haemostasi...

viewview our portfolio

Our Team

Rob Carroll

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
LE19 4XT

Tel: 0116 238 8200